Patents by Inventor Emer Clarke

Emer Clarke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel antibody compositions for preparing enriched mesenchymal progenitor preparations
    Publication number: 20040058397
    Abstract: The present invention relates to antibody composition that are useful in preparing enriched mesenchymal progenitor cell preparations. The invention also relates to kits for carrying out the processes and to the cell preparations prepared by the processes.
    Type: Application
    Filed: September 9, 2003
    Publication date: March 25, 2004
    Inventors: Terry E. Thomas, Emer Clarke
  • Antibody compositions for preparing enriched mesenchymal progenitor preparations
    Patent number: 6645727
    Abstract: The present invention relates to antibody composition that are useful in preparing enriched mesenchymal progenitor cell preparations. The invention also relates to kits for carrying out the processes and to the cell preparations prepared by the processes.
    Type: Grant
    Filed: May 25, 2001
    Date of Patent: November 11, 2003
    Assignee: StemCell Technologies Inc.
    Inventors: Terry Thomas, Emer Clarke
  • Novel antibody compositions for preparing enriched mesenchymal progenitor preparations
    Publication number: 20020058289
    Abstract: The present invention relates to antibody composition that are useful in preparing enriched mesenchymal progenitor cell preparations. The invention also relates to kits for carrying out the processes and to the cell preparations prepared by the processes.
    Type: Application
    Filed: May 25, 2001
    Publication date: May 16, 2002
    Inventors: Terry E. Thomas, Emer Clarke
  • Method for inhibiting mast cell and basophil activation
    Patent number: 5859017
    Abstract: In a method for treating or preventing allergy or allergic disorders an effective amount of a compound that inhibits intracellular generation of phosphatidic acid and diacylglycerol is administered. The intracellular generation of phosphatidic acid and diacylglycerol results from allergen presentation or mast cell/basophil activation.
    Type: Grant
    Filed: April 1, 1994
    Date of Patent: January 12, 1999
    Assignee: Cell Therapeutics, Inc.
    Inventors: Elisa Eiseman, Emer Clarke, Jack W. Singer, Stuart L. Bursten